PreemptiveAI, which is developing AI models to interpret biomedical signals, emerged from stealth with $6.4 million in funding, CEO Jamien McCullum tells Axios exclusively.
Why it matters: The company aims to interpret biomedical data from smartphones and wearable devices to help predict events like stroke or heart attack.
